Oct 27, 2026 07:00AM
Oct 18, 2026 08:00PM
Oct 12, 2026 02:18AM
Sep 8, 2026 04:05PM
Sep 8, 2026 04:05PM
Sep 2, 2026 07:05AM
Sep 1, 2026 09:09AM Protagonist Therapeutics (PTGX) PT Raised to $190 at BMO Capital
Sep 1, 2026 07:15AM
Sep 1, 2026 04:07AM
Aug 31, 2026 01:05PM
Aug 31, 2026 12:31PM
Aug 31, 2026 10:56AM
Aug 28, 2026 08:30PM
Aug 28, 2026 08:30PM Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera
Aug 18, 2026 04:05PM
Aug 10, 2026 04:12AM
Aug 6, 2026 02:34AM
Aug 5, 2026 04:05PM
Aug 4, 2026 04:05PM
Jul 17, 2026 05:06AM
Jul 16, 2026 04:05PM Protagonist Therapeutics Reports Granting of Inducement Awards
Jul 7, 2026 06:03AM
Jul 1, 2026 04:05PM
Jul 1, 2026 09:13AM
Jun 16, 2026 04:00PM
May 28, 2026 07:05AM
May 21, 2026 05:32AM
May 11, 2026 09:22AM BMO Capital Reiterates Outperform Rating on Protagonist Therapeutics (PTGX)
May 6, 2026 04:28AM
May 5, 2026 05:24PM
May 5, 2026 04:05PM
Apr 28, 2026 09:05AM
Apr 16, 2026 04:05PM
Apr 14, 2026 03:13PM
Apr 14, 2026 01:03PM Protagonist Therapeutics (PTGX) PT Raised to $121 at Truist Securities
Apr 6, 2026 04:06PM
Mar 28, 2026 10:05AM
Mar 28, 2026 10:05AM
Mar 18, 2026 03:39PM
Mar 18, 2026 12:17PM
Mar 18, 2026 12:14PM
Mar 18, 2026 10:28AM Truist Securities models $730M peak revenue for Protagonist Therapeutics (PTGX) in Icotyde royalties
Mar 18, 2026 08:05AM
Mar 18, 2026 08:05AM
Mar 2, 2026 06:47AM
Mar 2, 2026 06:01AM
Feb 26, 2026 04:51AM
Feb 25, 2026 05:15PM
Feb 25, 2026 04:05PM Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Jan 30, 2026 06:47AM

472,226 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All